Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality

HERBORT C. P., ABU EL ASRAR A. M., Yamamoto J. H., PAVESIO C. E., GUPTA V., KHAIRALLAH M., ...Daha Fazla

INTERNATIONAL OPHTHALMOLOGY, cilt.37, sa.6, ss.1383-1395, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 37 Sayı: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1007/s10792-016-0395-0
  • Dergi Adı: INTERNATIONAL OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1383-1395
  • İstanbul Üniversitesi Adresli: Evet

Özet

Vogt-Koyanagi-Harada (VKH) disease is a primary autoimmune stromal choroiditis. Aim of the study was to gather a body of evidence from the literature and from experts that systemic corticosteroid combined with non-steroidal immunosuppressive therapy should become the standard of care in initial-onset VKH disease.